Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine + Valsartan vs Losartan + HCT for LVH Regression
NCT00446563Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, valsartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
amlodipinevalsartan
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00446563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446563.